144 results
8-K
EX-1.1
ABBV
Abbvie Inc
26 Feb 24
Other Events
5:08pm
on the part of the Commission for additional information shall have been complied with to the reasonable satisfaction of counsel to the Underwriters
8-K
EX-5.1
ABBV
Abbvie Inc
26 Feb 24
Other Events
5:08pm
2
We have examined and relied on originals or copies certified or otherwise identified to our satisfaction of such documents, corporate records
8-K
EX-4.2
ABBV
Abbvie Inc
26 Feb 24
Other Events
5:08pm
. A Definitive Note may not be exchanged for a beneficial interest in a Global Note except upon satisfaction of the requirement set forth below. Upon
424B5
gh481foe1 6c
26 Feb 24
Prospectus supplement for primary offering
6:12am
S-8
EX-4.5
bh2w6qfn
22 Feb 24
Registration of securities for employees
5:50pm
S-8
EX-4.4
5wd0q4u58n
22 Feb 24
Registration of securities for employees
5:50pm
424B5
dyp ph63e
21 Feb 24
Prospectus supplement for primary offering
8:39am
8-K
EX-99.2
mzc0o pstdznw
6 Dec 23
AbbVie to Acquire Cerevel Therapeutics in Transformative Transaction to Strengthen Neuroscience Pipeline
5:28pm
8-K
y7how
6 Dec 23
AbbVie to Acquire Cerevel Therapeutics in Transformative Transaction to Strengthen Neuroscience Pipeline
5:28pm
8-K
EX-99.1
47poh20r9ry4h 7zam
6 Dec 23
AbbVie to Acquire Cerevel Therapeutics in Transformative Transaction to Strengthen Neuroscience Pipeline
5:28pm
8-K
EX-99.2
1ohc7
30 Nov 23
AbbVie to Acquire ImmunoGen, including its Flagship Cancer Therapy ELAHEREĀ® (mirvetuximab soravtansine-gynx), Expanding Solid Tumor Portfolio
8:47am
8-K
EX-99.1
m7emc8z
30 Nov 23
AbbVie to Acquire ImmunoGen, including its Flagship Cancer Therapy ELAHEREĀ® (mirvetuximab soravtansine-gynx), Expanding Solid Tumor Portfolio
8:47am
8-K
1hifs5kk9ug
30 Nov 23
AbbVie to Acquire ImmunoGen, including its Flagship Cancer Therapy ELAHEREĀ® (mirvetuximab soravtansine-gynx), Expanding Solid Tumor Portfolio
8:47am
S-8
EX-5.1
c0u uphun
4 Nov 22
Registration of securities for employees
5:45pm
S-3ASR
EX-5.1
rjgk cy0887i
22 Feb 22
Automatic shelf registration
5:02pm